Evanston, Ill.-based Endeavor Health recorded an operating loss of $33.9 million (-0.5% operating margin) in 2025, an improvement from a $494.3 million loss (-8.3% margin) in 2024, driven by a significant reduction in legal settlement costs.
In 2025, Endeavor incurred $62.3 million in legal settlement costs, compared to $457.2 million in 2024, according to the system’s April 20 financial report. The system’s 2024 legal settlement costs included $453 million in settlements related to sexual abuse claims against a former physician.
Endeavor’s operating income before legal settlement costs was $28.5 million (0.4% margin), compared to an operating loss of $37.1 million (-0.6% margin) in 2024.
The system reported total revenue of $6.4 billion for the 12 months ended Dec. 31, up from $5.9 billion during the same period in 2024. Patient service revenue was $5.7 billion, up from $5.4 billion. Premium revenue was $189.8 million, up from $160.3 million.
Total operating expenses were $6.4 billion in 2025, up from $6 billion in 2024. Salaries and benefits totaled $3.4 billion, up from $3.2 billion. Supplies, services and other costs totaled $2.22 billion, up from $2.17 billion.
Endeavor reported a net income of $663.3 million in 2025, up from a net loss of $296.3 million in 2024.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
